Studies link gut dysbiosis to pancreatic cancer, offering pathways for early detection

The gut microbiome’s impact on pancreatic cancer highlights potential for early screening and fecal microbiota transplantation in improving treatment efficacy.

FDA issues second CRL to Supernus for Parkinson’s drug-device combo

It seems Supernus Pharmaceuticals will need a super effort to get its Parkinson’s treatment approved. The FDA rejected the company’s therapy for a second time

April 9, 2024

Alzheimer’s and X Chromosomes; Identifying Pediatric MOGAD; Vladimir Lenin’s Death

A large-scale X chromosome-wide association study of Alzheimer’s disease identified SLC9A7 as a novel risk locus. (JAMA Neurology) Investigational fosgonimeton did not meet its primary

September 11, 2024

Denosumab biosimilar by Sandoz Group for Humoral Hypercalcemia of Malignancy: Likelihood of Approval

Denosumab biosimilar is under clinical development by Sandoz Group and currently in Pre-Registration for Humoral Hypercalcemia of Malignancy.

March 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.